Home Health Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents
HealthNews

Mpox: WHO Approves Administration of Jynneos Vaccine for Adolescents

430

On Monday, the World Health Organisation (WHO) announced its approval of Bavarian Nordic’s Jynneos vaccine for adolescents aged 12 to 17. This group is considered particularly vulnerable to mpox outbreaks. The vaccine was prequalified by the WHO on October 8, 2024, following its earlier approval for adults.

The approval comes after the European Union authorised the vaccine for adolescents in September. The WHO declared mpox a global public health emergency in August, after a new strain of the virus spread across many countries.

Bavarian Nordic is set to begin clinical trials to assess the vaccine’s safety for children aged two to 12. The trials are expected to start in October. Meanwhile, the U.S. FDA has approved the vaccine for adults.

Another mpox vaccine, LC16, developed by Japan’s KM Biologics, is already approved for use in children but requires a specialised needle for administration.

Read More:

About The Author

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

NewsWorld

AES Dismisses Fake Document on “Irreversible” CFA Franc Withdrawal No, the Sahel Alliance Has Not

The Alliance of Sahel States (AES), comprising Mali, Burkina Faso and Niger,...

NewsWorld

Burkina Faso, Mali, Niger News Agencies Seal Partnership at UACO 2025

The news agencies of the Alliance of Sahel States (AES) have signed...

NewsWorld

Niger Foreign Minister Meets Venezuelan President Nicolás Maduro to Deepen Bilateral Ties

Niger’s Minister of Foreign Affairs, Cooperation and Nigeriens Abroad, Yaou Sangaré Bakary,...

News

Nigeria at 65: From Fastest-Growing Economy to Total Failure Under Western-Backed APC Rule

As Nigeria marks its 65th anniversary of independence, official celebrations have been...